CD8A and neoplasm: By contrast, the proliferation of CD8+ T cells was similarly pronounced if an αEpCAM–αCD28 control bsAb or no αEpCAM bsAb was used, suggesting that (co)stimulation on HUVEC in the transwell insert was sufficient and no further boost by tumor cell crosslinking was required to trigger proliferation of CD8+ T cells.